Blenrep

Description

Blenrep is an innovative medicine for multiple myeloma.

A drug with a unique mechanism of action for the treatment of adults with relapsed or treatment-resistant multiple myeloma, in patients who have previously received at least 4 drugs for treatment.

Active ingredient: Belantamab mafodotin

Prescription medicine